JP2015517504A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015517504A5 JP2015517504A5 JP2015511877A JP2015511877A JP2015517504A5 JP 2015517504 A5 JP2015517504 A5 JP 2015517504A5 JP 2015511877 A JP2015511877 A JP 2015511877A JP 2015511877 A JP2015511877 A JP 2015511877A JP 2015517504 A5 JP2015517504 A5 JP 2015517504A5
- Authority
- JP
- Japan
- Prior art keywords
- chelate complex
- seq
- pharmaceutical composition
- interferon
- oligonucleotide consisting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261648711P | 2012-05-18 | 2012-05-18 | |
| US61/648,711 | 2012-05-18 | ||
| US201261695035P | 2012-08-30 | 2012-08-30 | |
| US61/695,035 | 2012-08-30 | ||
| PCT/CA2013/050379 WO2013170386A1 (en) | 2012-05-18 | 2013-05-17 | Oligonucleotide chelate complex-polypeptide compositions and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015517504A JP2015517504A (ja) | 2015-06-22 |
| JP2015517504A5 true JP2015517504A5 (enExample) | 2016-07-07 |
Family
ID=49581470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015511877A Pending JP2015517504A (ja) | 2012-05-18 | 2013-05-17 | オリゴヌクレオチドキレート錯体−ポリペプチド組成物および方法 |
Country Status (34)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3199635B1 (en) | 2007-05-11 | 2019-02-06 | Adynxx, Inc. | Gene expression and pain |
| CN104487096B (zh) | 2012-05-10 | 2020-09-15 | 埃迪恩克斯股份有限公司 | 用于活性成分递送的配制物 |
| EP2890403A4 (en) * | 2012-08-30 | 2016-03-09 | Replicor Inc | METHOD FOR THE TREATMENT OF HEPATITIS B AND HEPATITIS D INFECTIONS |
| RS64833B1 (sr) * | 2014-07-10 | 2023-12-29 | Replicor Inc | Helatni fosforotioatni polimeri nukleinske kiseline za upotrebu u kombinaciji sa inhibitorom hbv polimeraze za lečenje virusnih infekcija hepatitisa b i hepatitisa d |
| AU2015301491A1 (en) | 2014-08-15 | 2017-02-02 | Adynxx, Inc. | Oligonucleotide decoys for the treatment of pain |
| MX2021005357A (es) * | 2018-11-08 | 2021-06-30 | Aligos Therapeutics Inc | Polimeros oligonucleotidos que inhiben el transporte de antigeno s y metodos. |
| US11166976B2 (en) | 2018-11-08 | 2021-11-09 | Aligos Therapeutics, Inc. | S-antigen transport inhibiting oligonucleotide polymers and methods |
| EP4728073A1 (en) * | 2023-06-16 | 2026-04-22 | Ractigen Therapeutics | Oligonucleotide formulation |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2769114B2 (ja) * | 1993-10-29 | 1998-06-25 | サイクローン・ファーマシューティカルズ | ミニマルｂ型肝炎感染症治療用医薬組成物 |
| UA78726C2 (en) * | 2001-11-01 | 2007-04-25 | Sciclone Pharmaceuticals Inc | Pharmaceutical composition of thymosin alpha 1 conjugated with polyethylene glycol, method for production, and method for treatment |
| JP2005538186A (ja) * | 2002-09-13 | 2005-12-15 | レプリコール インコーポレーティッド | 非配列相補性の抗ウイルス性オリゴヌクレオチド |
| WO2004076474A2 (en) * | 2003-02-26 | 2004-09-10 | Intermune, Inc. | Polyethylene glycol modified interferon compositions and methods of use thereof |
| EP1677827B1 (en) * | 2003-10-27 | 2008-12-10 | Vertex Pharmaceuticals Incorporated | Combinations for hcv treatment |
| WO2006042418A1 (en) * | 2004-10-19 | 2006-04-27 | Replicor Inc. | Antiviral oligonucleotides |
| WO2007022642A2 (en) * | 2005-08-25 | 2007-03-01 | Replicor Inc. | Anti-inflammatory molecules and their uses |
| WO2007036016A1 (en) | 2005-09-29 | 2007-04-05 | Replicor Inc. | Therapeutic molecules and their uses |
| WO2007041279A2 (en) * | 2005-09-29 | 2007-04-12 | S-Cell Biosciences, Inc. | Methods to treat t-cell disorders using tisf |
| GB0715383D0 (en) * | 2007-08-08 | 2007-09-19 | Asterion Ltd | Interferon |
| WO2009065181A1 (en) * | 2007-11-21 | 2009-05-28 | Apollo Life Sciences Limited | Nanostructures suitable for delivery of agents |
| EP2229459B1 (en) | 2007-12-13 | 2014-08-27 | Alnylam Pharmaceuticals, Inc. | Methods and compositions for prevention or treatment of RSV infection |
| EP2268811A1 (en) * | 2008-03-07 | 2011-01-05 | Santaris Pharma A/S | Pharmaceutical compositions for treatment of microrna related diseases |
| CA2764683A1 (en) * | 2009-05-28 | 2010-12-02 | Joseph Collard | Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene |
| EP2512491B1 (en) * | 2009-10-16 | 2017-10-11 | Glaxo Group Limited | Hbv antisense inhibitors |
| KR20150039873A (ko) * | 2010-08-20 | 2015-04-13 | 레플리코르 인코포레이티드 | 올리고뉴클레오타이드 킬레이트 복합체 |
| EP2890403A4 (en) | 2012-08-30 | 2016-03-09 | Replicor Inc | METHOD FOR THE TREATMENT OF HEPATITIS B AND HEPATITIS D INFECTIONS |
-
2013
- 2013-05-17 CA CA2873529A patent/CA2873529C/en active Active
- 2013-05-17 SM SM20210319T patent/SMT202100319T1/it unknown
- 2013-05-17 HU HUE13791618A patent/HUE054875T2/hu unknown
- 2013-05-17 DK DK13791618.5T patent/DK2849798T3/da active
- 2013-05-17 MX MX2014014021A patent/MX346239B/es active IP Right Grant
- 2013-05-17 KR KR1020147035252A patent/KR102068109B1/ko active Active
- 2013-05-17 AU AU2013262416A patent/AU2013262416B2/en active Active
- 2013-05-17 WO PCT/CA2013/050379 patent/WO2013170386A1/en not_active Ceased
- 2013-05-17 ES ES13791618T patent/ES2873844T3/es active Active
- 2013-05-17 EA EA201401278A patent/EA035967B1/ru unknown
- 2013-05-17 JP JP2015511877A patent/JP2015517504A/ja active Pending
- 2013-05-17 TW TW102117594A patent/TWI635864B/zh not_active IP Right Cessation
- 2013-05-17 SI SI201331881T patent/SI2849798T1/sl unknown
- 2013-05-17 HR HRP20210840TT patent/HRP20210840T1/hr unknown
- 2013-05-17 CN CN201380026009.3A patent/CN104349793B/zh active Active
- 2013-05-17 PT PT137916185T patent/PT2849798T/pt unknown
- 2013-05-17 LT LTEP13791618.5T patent/LT2849798T/lt unknown
- 2013-05-17 BR BR112014028654A patent/BR112014028654A2/pt active Search and Examination
- 2013-05-17 NZ NZ703095A patent/NZ703095A/en unknown
- 2013-05-17 PL PL13791618T patent/PL2849798T3/pl unknown
- 2013-05-17 SG SG11201407599SA patent/SG11201407599SA/en unknown
- 2013-05-17 RS RS20210674A patent/RS62030B1/sr unknown
- 2013-05-17 EP EP13791618.5A patent/EP2849798B1/en active Active
- 2013-05-17 US US13/896,510 patent/US9492506B2/en active Active
- 2013-05-17 MY MYPI2014003189A patent/MY168778A/en unknown
-
2014
- 2014-11-06 IL IL235548A patent/IL235548B/en active IP Right Grant
- 2014-11-14 PH PH12014502551A patent/PH12014502551B1/en unknown
- 2014-11-18 CL CL2014003134A patent/CL2014003134A1/es unknown
- 2014-11-18 EC ECIEPI201427694A patent/ECSP14027694A/es unknown
- 2014-11-18 DO DO2014000264A patent/DOP2014000264A/es unknown
- 2014-11-18 CR CR20140527A patent/CR20140527A/es unknown
- 2014-11-19 CO CO14254322A patent/CO7131387A2/es unknown
- 2014-11-25 ZA ZA2014/08674A patent/ZA201408674B/en unknown
-
2021
- 2021-05-31 CY CY20211100467T patent/CY1124345T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015528449A5 (enExample) | ||
| JP2010503396A5 (enExample) | ||
| JP2016503800A5 (enExample) | ||
| JP4413996B2 (ja) | 抗ｂ型肝炎ウィルス活性を有するヌクレオシド | |
| HRP20201953T1 (hr) | Postupci i farmaceutski pripravci za liječenje virusne infekcije hepatitisom b | |
| JP2006516949A5 (enExample) | ||
| US6566344B1 (en) | β-L-2′-deoxy-nucleosides for the treatment of hepatitis B | |
| JP2004513070A5 (enExample) | ||
| TWI620568B (zh) | 用於治療ｂ型肝炎及ｄ型肝炎感染之方法 | |
| JP2013507439A5 (enExample) | ||
| JP2010514768A (ja) | ウイルス感染の治療のための化合物、及び医薬組成物 | |
| JP2015512860A5 (enExample) | ||
| JP2002522552A (ja) | Ｂ型肝炎の治療のためのβ−Ｌ−２’−デオキシ−ヌクレオシド | |
| WO2014165704A1 (en) | Hepatitis c viral infection treatment using a combination of compounds | |
| JP2013522302A5 (enExample) | ||
| JP2016531144A5 (enExample) | ||
| CA2498731A1 (en) | .beta.-l-2'-deoxynucleosides for the treatment of resistant hbv strains and combination therapies | |
| JP2004533401A5 (enExample) | ||
| CN103906759A (zh) | 用于治疗病毒感染的化合物和药物组合物 | |
| HRP20231400T1 (hr) | Kelirani fosforotioirani polimeri nukleinskih kiselina, namijenjeni upotrebi u kombinaciji s inhibitorom hbv polimeraze u liječenju infekcija virusima hepatitisa b i hepatitisa d | |
| TWI635864B (zh) | 寡核苷酸螯合複合物－多肽組合物及方法 | |
| CN104968673A (zh) | 融合多肽及使用方法 | |
| Bruno et al. | Boceprevir in addition to standard of care enhanced SVR in hepatitis C virus (HCV) genotype-1 with advanced fibrosis/cirrhosis: subgroup analysis of SPRINT-2 and RESPOND-2 studies | |
| JP7712982B2 (ja) | 融合ポリペプチドおよび使用方法 | |
| JP2010520921A5 (enExample) |